Other Cancers
- Eye and OrbitLEAHRN (Late Effects After High-Risk Neuroblastoma) StudyPrincipal Investigator: Farzana Pashankar
- Other SkinA Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer PatientsPrincipal Investigator: Jonathan Leventhal
- Lip, Oral Cavity and Pharynx, Other Skin, Soft TissueA Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination With RP1 in Patients With Advanced Cutaneous Squamous Cell CarcinomaPrincipal Investigator: Aarti Bhatia
- Other SkinA Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (KEYNOTE-630)Principal Investigator: Aarti Bhatia
- Other SkinA Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell CarcinomaPrincipal Investigator: Harriet Kluger